p53 Pathway in Postnatal Growth and Stem Cell Behavior
p53 产后生长和干细胞行为途径
基本信息
- 批准号:7005295
- 负责人:
- 金额:$ 19.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:apoptosisatrophybiological signal transductioncachexiacell differentiationcell growth regulationcell proliferationcellular oncologydevelopmental geneticsgene expressiongenetic modelsgenetic regulationgenetically modified animalslaboratory mousemuscle satellite cellmusculoskeletal regenerationmyoblastsmyogenesisneoplasm /cancer geneticsnuclear factor kappa betap53 gene /proteinprotein protein interactionstriated musclestissue /cell culturetumor necrosis factor alpha
项目摘要
The processes governing stem cell generation and subsequent stem cell renewal and differentiation are poorly understood. With the exception of lower vertebrates, the existence of an identifiable and functional compartment of postnatal pluripotent stem cells which participate in multiple lineages has been difficult to identify in higher vertebrates. What limited regenerative potential mammals display declines rapidly with age and is compromised further in many disease states. We have been studying the role of PW1 which is a p53 induced gene involved in cell death and which also mediates the TNFalpha/NFkB signaling pathway. During development, PW1 is expressed during early mesodermal specification and maintained at high levels in stem cells residing in post-natal skeletal muscle. Taken together, these observations lead to the
proposal that PW1 mediates stem cell behavior through p53 and cytokine/NF_B signaling pathways in these cells. We note that there is little information available regarding postnatal pluripotent stem cells due in part to their inability to undergo significant expansion in vitro and a high sensitivity to their host environment including inflammatory cytokines (i.e. TNFalpha).
Related to these studies is the fact that skeletal muscle is highly sensitive to chronically elevated levels of inflammatory cytokines and undergoes wasting (cachexia) in response to TNFalpha which accounts for significant patient morbidity in cancer and chronic infection. A similar process of muscle atrophy accompanies aging and is also seen in mice with increased p53
activity. Data obtained in our laboratory has revealed an unexpected mechanistic link between the TNFalpha and p53 pathways that is unique to skeletal muscle cells which is mediated through PW1 activity. We propose these signaling pathways are active in the stem cell population and in a manner related to the ability of p53 to dictate cell fate outcomes, the p53-PW1 pathway may modulate stem cell number and competence in postnatal muscle tissue. In this proposal, we will use in vitro models (cell culture) and in vivo (mouse) models to explore the roles of PW1, p53 and cytokine signaling pathways in skeletal muscle stress responses and stem cell regulation. The relationship between the muscle stress/cachectic responses,
aging and stem cell regulation is poorly understood although stem cells are required to maintain muscle growth and are thought to diminish in number and/or potential during postnatal life. We will address the central hypothesis that p53/PW1 pathways converge to regulate stem cell allocation and fate in the skeletal muscle lineage.
对干细胞产生和随后的干细胞更新和分化的过程对了解很少了解。除较低的脊椎动物外,在较高的脊椎动物中很难识别出参与多个谱系的产后多能干细胞的可识别和功能区室。有限的再生潜在哺乳动物显示出随着年龄的增长而迅速下降,并且在许多疾病状态下进一步损害。我们一直在研究PW1的作用,PW1是参与细胞死亡的p53诱导基因,还介导了TNFALPHA/NFKB信号通路。在发育过程中,PW1在中胚层规格的早期表达,并保持在产后骨骼肌中的干细胞中的高水平。综上所述,这些观察结果导致
PW1的建议通过这些细胞中的p53和细胞因子/NF_B信号通路介导干细胞行为。我们注意到,几乎没有关于产后多能干细胞的信息,部分原因是它们无法在体外进行显着扩张和对宿主环境(包括炎性细胞因子(即tnfalpha))的高敏感性。
与这些研究相关的事实是,骨骼肌对炎症性细胞因子的慢性升高水平高度敏感,并且经历了浪费(卡希克西)对TNFALPHA的响应,这构成了癌症和慢性感染的患者发病率的显着发病。伴随衰老的类似肌肉萎缩的过程,在p53增加的小鼠中也可以看到
活动。在我们的实验室中获得的数据揭示了TNFALPHA和p53途径之间的意外机械联系,这是骨骼肌细胞独有的,这是通过PW1活性介导的。我们提出这些信号通路在干细胞种群中是活跃的,并且与p53决定细胞命运结果的能力有关,p53-PW1途径可能会调节产后肌肉组织中的干细胞数量和能力。在此提案中,我们将使用体外模型(细胞培养)和体内(小鼠)模型来探索PW1,p53和细胞因子信号通路在骨骼肌应激反应和干细胞调节中的作用。肌肉应力/缓存反应之间的关系,
尽管需要干细胞来维持肌肉生长,但人们认为衰老和干细胞的调节尚不清楚,并且被认为在产后生活期间的数量和/或潜力减少。我们将解决p53/pw1途径在骨骼肌谱系中调节干细胞分配和命运的中心假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David A Sassoon其他文献
David A Sassoon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David A Sassoon', 18)}}的其他基金
Organochlorine disruption of WNT gene pathway in female reproductive tract
有机氯破坏女性生殖道 WNT 基因通路
- 批准号:
6587641 - 财政年份:2002
- 资助金额:
$ 19.44万 - 项目类别:
PW1--A mediator of cell survival by NFKB and cell death by p53
PW1——NFKB 介导的细胞存活和 p53 介导的细胞死亡的介质
- 批准号:
6563940 - 财政年份:2002
- 资助金额:
$ 19.44万 - 项目类别:
Organochlorine disruption of WNT gene pathway in female reproductive tract
有机氯破坏女性生殖道 WNT 基因通路
- 批准号:
6578819 - 财政年份:2002
- 资助金额:
$ 19.44万 - 项目类别:
PW1--A mediator of cell survival by NFKB and cell death by p53
PW1——NFKB 介导的细胞存活和 p53 介导的细胞死亡的介质
- 批准号:
6416246 - 财政年份:2001
- 资助金额:
$ 19.44万 - 项目类别:
PW1--A mediator of cell survival by NFKB and cell death by p53
PW1——NFKB 介导的细胞存活和 p53 介导的细胞死亡的介质
- 批准号:
6323780 - 财政年份:2000
- 资助金额:
$ 19.44万 - 项目类别:
相似国自然基金
傣药芽命几及单体异鼠李素调节蛋白合成-分解代谢治疗骨骼肌萎缩的作用及机制研究
- 批准号:82305431
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MLIP调控AP-1稳定性促进缺血性心力衰竭合并骨骼肌萎缩的机制研究
- 批准号:82370382
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Myostatin-Akirin1介导的肌卫星细胞功能探明肾衰营养胶囊对CKD-PEW骨骼肌萎缩的作用机制
- 批准号:82305168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于新型深度学习算法和多组学研究策略鉴定非编码区剪接突变在肌萎缩侧索硬化症中的分子机制
- 批准号:82371878
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ActRIIB小分子抑制剂和降解剂改善肿瘤恶病质肌萎缩的作用及机制研究
- 批准号:82373317
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 19.44万 - 项目类别:
Regulation of OXPHOS Assembly in Skeletal Muscles
骨骼肌中 OXPHOS 组装的调节
- 批准号:
10660712 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Developing HTS assays for identifying NLK activators to target Huntington's disease
开发 HTS 检测方法来鉴定 NLK 激活剂以靶向亨廷顿病
- 批准号:
10783153 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Caspase-mediated nuclear pore complex trimming in myogenesis and muscular dystrophies
肌生成和肌营养不良中半胱天冬酶介导的核孔复合物修剪
- 批准号:
10591953 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Mechanism of mitochondria-induced proteostatic signaling and progressive muscle atrophy during aging.
衰老过程中线粒体诱导的蛋白质抑制信号传导和进行性肌肉萎缩的机制。
- 批准号:
10825174 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别: